Nabeel Mohsin Akhter
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Nabeel Mohsin Akhter has a total of 33 co-authors. Here are the top co-authors by number of shared publications:
Abheek Ghosh
Department of Interventional Radiology, University of Maryland School of Medicine, Baltimore, Maryland, United States
3 shared publicationsSheena Anand
Department of Interventional Radiology, University of Maryland School of Medicine, Baltimore, Maryland, United States
2 shared publicationsAbdullah Al Khalifah
Department of Interventional Radiology, University of Maryland, Baltimore, Maryland, United States
1 shared publication- Abheek Ghosh
Division of Vascular and Interventional Radiology, Department of Diagnostic Radiology and Nuclear Medicine, University of Maryland Medical Center, 22 S. Greene Street, Suite: G2K10, Baltimore, MD 21201, USA
1 shared publication - Ahmed Kamel Abdel Aal
Department of Interventional Radiology, The University of Texas Health Science Center at Houston, Houston, TX 77030, USA
1 shared publication - Andrew S. Kennedy
Sarah Cannon Research Institute, Nashville, Tennessee
1 shared publication
Latest Publications
- 1 October 2022
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 305 (1) , 228-236
Survival and Toxicities after 90Y Transarterial Radioembolization of Metastatic Colorectal Cancer in the RESIN Registry
Transarterial radioembolization with yttrium 90 microspheres resulted in 15.0-month overall survival in 498 participants with metastatic colorectal cancer: 17.4 months when integrated with second-l... Background Patients with unresectable, chemorefractory hepatic metastases from colorectal cancer have considerable mortality. The role of transarterial radioembolization (TARE) with yttrium 90 (90Y...
- 1 October 2022
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 305 (1) , 228-236
Survival and Toxicities after 90Y Transarterial Radioembolization of Metastatic Colorectal Cancer in the RESIN Registry
Transarterial radioembolization with yttrium 90 microspheres resulted in 15.0-month overall survival in 498 participants with metastatic colorectal cancer: 17.4 months when integrated with second-l... Background Patients with unresectable, chemorefractory hepatic metastases from colorectal cancer have considerable mortality. The role of transarterial radioembolization (TARE) with yttrium 90 (90Y...
- Open Access
- 17 August 2022
- Published by Scientific Scholar in Journal of Clinical Imaging Science
- Vol. 12, 49
Catheter-directed computed tomography angiography: A pictorial essay
Catheter-directed computed tomography angiography (CDCTA) is an imaging technique where CT images are acquired after selective catheterization of a vessel. Images obtained in this fashion provide several advantages over conventional imaging techniques such as fluoroscopic angiography, digital subtraction angiography, cone-beam CT, and conventional CT angiography. At this point, there is still limited literature on the subject, with prior studies examining a small number of potential uses. The goal of this pictorial essay is to illustrate our single tertiary care center experience using CDCTA.
- 17 August 2022
- Published by Scientific Scholar in Journal of Clinical Imaging Science
- Vol. 12, 49
Open AccessCatheter-directed computed tomography angiography: A pictorial essay
Catheter-directed computed tomography angiography (CDCTA) is an imaging technique where CT images are acquired after selective catheterization of a vessel. Images obtained in this fashion provide several advantages over conventional imaging techniques such as fluoroscopic angiography, digital subtraction angiography, cone-beam CT, and conventional CT angiography. At this point, there is still limited literature on the subject, with prior studies examining a small number of potential uses. The goal of this pictorial essay is to illustrate our single tertiary care center experience using CDCTA.
- Open Access
- 15 July 2022
- Published by Scientific Scholar in Journal of Clinical Imaging Science
- Vol. 12, 38
Transradial versus transfemoral arterial access in DEB-TACE for hepatocellular carcinoma
Objectives: Transradial access has become increasingly popular in body interventional procedures but has not been ubiquitously adapted. This retrospective study compares the efficacy of this approach versus transfemoral access in hepatocellular carcinoma (HCC) patients who underwent drug-eluting bead transarterial chemoembolization (DEB-TACE). Materials and Methods: A total of 130 HCC patients underwent 146 DEB-TACE procedures within our institution from June 2015 to May 2020. About 90 and 56 procedures were logged for the transradial and transfemoral cohorts, respectively. Peak skin dose, fluoroscopy time, administered contrast volume, total procedure time, and equipment cost data for each procedure were reviewed to evaluate for statistical differences between the two groups. Results: All 146 cases were technically successful without major complications or access failures in either group. No statistical differences were present between the two access groups in regards to peak skin dose or fluoroscopy time. Transradial access recorded a significantly higher contrast volume (P < 0.05), and a significantly longer procedural time than transfemoral access (P < 0.01). However, transradial access also displayed a significantly lower procedural equipment cost (P < 0.01) between the two groups. Conclusion: Transradial DEB-TACE has similar trends to transfemoral DEB-TACE in several pertinent radiation parameters and is also significantly more cost-efficacious. The results of this investigation suggest the consideration of transradial access whenever viable as an alternative to transfemoral access in the DEB-TACE treatment of HCC patients.
- 15 July 2022
- Published by Scientific Scholar in Journal of Clinical Imaging Science
- Vol. 12, 38
Open AccessTransradial versus transfemoral arterial access in DEB-TACE for hepatocellular carcinoma
Objectives: Transradial access has become increasingly popular in body interventional procedures but has not been ubiquitously adapted. This retrospective study compares the efficacy of this approach versus transfemoral access in hepatocellular carcinoma (HCC) patients who underwent drug-eluting bead transarterial chemoembolization (DEB-TACE). Materials and Methods: A total of 130 HCC patients underwent 146 DEB-TACE procedures within our institution from June 2015 to May 2020. About 90 and 56 procedures were logged for the transradial and transfemoral cohorts, respectively. Peak skin dose, fluoroscopy time, administered contrast volume, total procedure time, and equipment cost data for each procedure were reviewed to evaluate for statistical differences between the two groups. Results: All 146 cases were technically successful without major complications or access failures in either group. No statistical differences were present between the two access groups in regards to peak skin dose or fluoroscopy time. Transradial access recorded a significantly higher contrast volume (P < 0.05), and a significantly longer procedural time than transfemoral access (P < 0.01). However, transradial access also displayed a significantly lower procedural equipment cost (P < 0.01) between the two groups. Conclusion: Transradial DEB-TACE has similar trends to transfemoral DEB-TACE in several pertinent radiation parameters and is also significantly more cost-efficacious. The results of this investigation suggest the consideration of transradial access whenever viable as an alternative to transfemoral access in the DEB-TACE treatment of HCC patients.
- Open Access
- 28 May 2022
- Published by Elsevier in Radiology Case Reports
- Vol. 17 (8) , 2603-2606
Percutaneous CT-guided superior mesenteric vein access for portal vein recanalization-transjugular intrahepatic portosystemic shunt
- 28 May 2022
- Published by Elsevier in Radiology Case Reports
- Vol. 17 (8) , 2603-2606
Open AccessPercutaneous CT-guided superior mesenteric vein access for portal vein recanalization-transjugular intrahepatic portosystemic shunt
- Open Access
- 12 May 2022
- Published by Scientific Scholar in Journal of Clinical Imaging Science
- Vol. 12, 27
Transradial versus transfemoral arterial access in Yttrium-90 microspheres radioembolization for hepatocellular carcinoma
OBJECTIVE: Transradial access has become more popular in body intervention procedures but has not been ubiquitously adapted. This study assesses the efficacy of this approach in Yttrium-90 labeled microspheres radioembolization. To compare transradial to transfemoral access in hepatocellular carcinoma patients who underwent Yttrium-90 radioembolization. MATERIALS AND METHODS: A total of 244 hepatocellular carcinoma patients underwent 337 radioembolization procedures at our institute from May 2014 to May 2020. The transradial access-group included 188 patients (252 procedures) while the transfemoral access group had 63 patients (85 procedures). The recovery time, fluoroscopy time, contrast volume, peak radiation dose, and equipment cost for each procedure were all reviewed to evaluate for statistical differences between the two groups. RESULTS: The transradial cohort recorded a significantly shorter (P < 0.01) mean recovery time (from the end of the procedure to discharge) and had a significantly shorter (P < 0.05) use of contrast volume versus the transfemoral group. In addition, the radiation dose and fluoroscopy time were lower in the transradial subset, although not statistically different. Furthermore, the overall cost for procedural equipment was significantly less (P < 0.01) in the transradial cohort than in the transfemoral. No major complications were reported in the transradial group, while one pseudoaneurysm was noted in the transfemoral group. CONCLUSION: With respect to many pertinent parameters, transradial access was evaluated as being more advantageous than transfemoral access. The results of this study suggest that transradial access should be considered more often, whenever feasible, as an option in the Yttrium-90 treatment of hepatocellular carcinoma patients.
- 12 May 2022
- Published by Scientific Scholar in Journal of Clinical Imaging Science
- Vol. 12, 27
Open AccessTransradial versus transfemoral arterial access in Yttrium-90 microspheres radioembolization for hepatocellular carcinoma
OBJECTIVE: Transradial access has become more popular in body intervention procedures but has not been ubiquitously adapted. This study assesses the efficacy of this approach in Yttrium-90 labeled microspheres radioembolization. To compare transradial to transfemoral access in hepatocellular carcinoma patients who underwent Yttrium-90 radioembolization. MATERIALS AND METHODS: A total of 244 hepatocellular carcinoma patients underwent 337 radioembolization procedures at our institute from May 2014 to May 2020. The transradial access-group included 188 patients (252 procedures) while the transfemoral access group had 63 patients (85 procedures). The recovery time, fluoroscopy time, contrast volume, peak radiation dose, and equipment cost for each procedure were all reviewed to evaluate for statistical differences between the two groups. RESULTS: The transradial cohort recorded a significantly shorter (P < 0.01) mean recovery time (from the end of the procedure to discharge) and had a significantly shorter (P < 0.05) use of contrast volume versus the transfemoral group. In addition, the radiation dose and fluoroscopy time were lower in the transradial subset, although not statistically different. Furthermore, the overall cost for procedural equipment was significantly less (P < 0.01) in the transradial cohort than in the transfemoral. No major complications were reported in the transradial group, while one pseudoaneurysm was noted in the transfemoral group. CONCLUSION: With respect to many pertinent parameters, transradial access was evaluated as being more advantageous than transfemoral access. The results of this study suggest that transradial access should be considered more often, whenever feasible, as an option in the Yttrium-90 treatment of hepatocellular carcinoma patients.
- 28 November 2019
- Published by Elsevier in The American Journal of Emergency Medicine
- Vol. 38 (11) , 2335-2342
Diagnostic value of CT contrast extravasation for major arterial injury after pelvic fracture: A meta-analysis
- 28 November 2019
- Published by Elsevier in The American Journal of Emergency Medicine
- Vol. 38 (11) , 2335-2342
Diagnostic value of CT contrast extravasation for major arterial injury after pelvic fracture: A meta-analysis